Application of Plasmocin in eliminating mycoplasma infection of human pluripotent stem cell
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective:To investigate the most effective dosage and optimal time window of Plasmocin in eliminating mycoplasma infection,and detect whether the drug exert negative effects on human pluriotent stem cell(hPSC) culture. Methods:hPSCS were treated with 25.0,12.5,8.5,5.0 μg/mL of Plasmocin. The efficiency for removing mycoplasma infection was compared by PCR. Directly differentiation of hPSC to forebrain neurons after rescued. Results:All of the concentrations for Plasmocin eradicated mycoplasma infection. However,the highest dosage (25.0 μg/mL)lead to toxic effects and the lowest dosage(5.0 μg/mL)required longer treatment time. The 12.5 μg/mL group had adverse effects on cell growth but the 8.5 μg/mL group contributed to hPSCs maintenance. After mycoplasma elimination,hPSC efficiently differentiated to forebrain neurons. Furthermore,after 9 months post-Plasmocin treatment,mycoplasam was undetected on hPSC. Conclusion:One week treatment with 8.5 μg/mL Plasmocin completely eradicated mycoplasma contamination without affecting hPSC maintenance and differentiation.

    Reference
    Related
    Cited by
Get Citation

Cao Shiying, Qu Zhuangyin, Yuan Fang, Liu Yan. Application of Plasmocin in eliminating mycoplasma infection of human pluripotent stem cell[J].,2016,(8):905-911.

Copy
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:March 17,2016
  • Revised:
  • Adopted:
  • Online: August 19,2016
  • Published:
Article QR Code